| 1 |
22357208 | Expression, purification and characterization of the interferon-inducible, antiviral and tumour-suppressor protein, human RNase L. | 2012 Mar |
2 |
| 2 |
19749291 | Introduction of 8-methyladenosine into 2', 5'-oligoadenylate (2-5A) 2'-terminus induces dramatic shift in binding site of RNase L. | 2009 |
2 |
| 3 |
17263642 | Inhibition of HIV type 1 replication in CD4+ and CD14+ cells purified from HIV type 1-infected individuals by the 2-5A agonist immunomodulator, 2-5A(N6B). | 2007 Jan |
2 |
| 4 |
17535916 | Small-molecule activators of RNase L with broad-spectrum antiviral activity. | 2007 Jun 5 |
1 |
| 5 |
16203993 | A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L. | 2005 Oct 11 |
1 |
| 6 |
16241858 | Mapping of the human RNASEL promoter and expression in cancer and normal cells. | 2005 Oct |
2 |
| 7 |
17200614 | Induction of the interferon-inducible RNA-degrading enzyme, RNase L, by stress-inducing agents in the human cervical carcinoma cells. | 2004 May |
1 |
| 8 |
11152576 | Caspase-dependent apoptosis by 2',5'-oligoadenylate activation of RNase L is enhanced by IFN-beta. | 2000 Dec |
2 |
| 9 |
10524248 | Transcriptional induction of p69 2'-5'-oligoadenylate synthetase by interferon-alpha is stimulated by 12-O-tetradecanoyl phorbol-13-acetate through IRF/ISRE binding motifs. | 1999 Sep 3 |
1 |
| 10 |
9525594 | RNase L mediates the antiviral effect of interferon through a selective reduction in viral RNA during encephalomyocarditis virus infection. | 1998 Apr |
1 |
| 11 |
9660177 | RNase L inhibitor (RLI) antisense constructions block partially the down regulation of the 2-5A/RNase L pathway in encephalomyocarditis-virus-(EMCV)-infected cells. | 1998 Jun 1 |
2 |
| 12 |
9660242 | Localization of a molecular form of interferon-regulated RNase L in the cytoskeleton. | 1998 Jun |
1 |
| 13 |
9260891 | Protein kinase C is required for induction of 2',5'-oligoadenylate synthetases. | 1997 Aug 1 |
1 |
| 14 |
8471593 | Pharmacodynamics of biological response in vivo after single and multiple doses of interferon-beta. | 1993 Apr |
1 |
| 15 |
1289408 | Absence of biological effects of orally administered interferon-beta ser. | 1992 Dec |
2 |
| 16 |
1379287 | Cell cycle regulation (G1) by autocrine interferon and dissociation between autocrine interferon and 2',5'-oligoadenylate synthetase expression. | 1992 May |
1 |
| 17 |
2472992 | Enhancement of interferon-induced 2-5 oligoadenylate synthetase activity by retinoic acid in human histiocytic lymphoma U937 cells and WISH cells. | 1989 Mar |
1 |
| 18 |
2523019 | Interferon and (2'-5')oligoadenylate enhance the expression of low affinity receptors for IgE (Fc epsilon R2/CD23) on the human monoblast cell line U937. | 1989 Mar |
1 |
| 19 |
2466091 | Cell cycle regulation (G1) by autocrine interferon and dissociation between autocrine interferon and 2',5'-oligoadenylate synthetase expression. | 1988 Dec |
1 |
| 20 |
2459906 | In vivo and in vitro induction of (2'-5') oligoadenylate synthetase by human interferons in leukocytes from healthy donors and patients with renal cancer and hairy cell leukemia. | 1987 Jul-Sep |
1 |
| 21 |
3585079 | 2',5'-Oligoadenylate synthetase activity in peripheral blood lymphocytes as a clinical marker in interferon therapy for chronic hepatitis B. | 1987 Feb |
2 |